Clovis Oncology to Present at 2019 Wells Fargo Healthcare Conference
August 28 2019 - 8:05AM
Business Wire
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that
Patrick J. Mahaffy, Chief Executive Officer and President, will
present at the 2019 Wells Fargo Healthcare Conference on Thursday,
September 5, 2019 at 8:35 AM Eastern Time. The conference will be
held at the Westin Copley Place in Boston, MA.
A live webcast of the presentation can be accessed through the
investor relations section of the Company’s website at
www.clovisoncology.com. Following the live presentation, a replay
of the webcast will be available on the Company’s website for 30
days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer
agents in the U.S., Europe and additional international markets.
Clovis Oncology targets development programs at specific subsets of
cancer populations, and simultaneously develops, with partners, for
those indications that require them, diagnostic tools intended to
direct a compound in development to the population that is most
likely to benefit from its use. Clovis Oncology is headquartered in
Boulder, Colorado; please visit www.clovisoncology.com for more
information, including additional office locations in the U.S. and
Europe.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190828005220/en/
Anna Sussman 303.625.5022 asussman@clovisoncology.com
Breanna Burkart 303.625.5023 bburkart@clovisoncology.com
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Apr 2023 to Apr 2024